Literature DB >> 9725198

Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptor.

S Lienenklaus1, R S Ames, M A Tornetta, H M Sarau, J J Foley, T Crass, B Sohns, U Raffetseder, M Grove, A Hölzer, A Klos, J Köhl, W Bautsch.   

Abstract

The interaction of human anaphylatoxin C4a with the guinea pig (gp) and human (hu) C3a receptors (C3aR) was analyzed using human rC4a, which exhibited C4a-specific activity on guinea pig platelets. A gpC3aR of 475 residues with a large second extracellular loop and a peptide sequence approximately 60% identical to the huC3aR was isolated from a genomic DNA library and found to be expressed in guinea pig heart, lung, and spleen. HEK-293 cells cotransfected with this clone, and a cDNA encoding G alpha-16 specifically bound (Kd = 1.6+/-0.7 nM) and responded functionally to C3a with an intracellular calcium mobilization (ED50 = 0.18+/-0.02 nM). Human rC4a weakly bound to both the hu- and gpC3aR (IC50 > 1 microM). However, only HEK-293 cells expressing the gpC3aR responded functionally to rC4a (ED50 = 8.7+/-0.52 nM), while cells expressing the huC3aR did not (c < or = 1 microM). Thus, through an interaction with the C3aR, huC4a may elicit anaphylatoxic effects in guinea pigs but not in man.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725198

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  C4a: An Anaphylatoxin in Name Only.

Authors:  Scott R Barnum
Journal:  J Innate Immun       Date:  2015-02-06       Impact factor: 7.349

Review 2.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  Complement-activation fragment C4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4.

Authors:  HongBin Wang; Daniel Ricklin; John D Lambris
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-26       Impact factor: 11.205

4.  Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study.

Authors:  Ying Xin; Elisabeth Hertle; Carla J H van der Kallen; Casper G Schalkwijk; Coen D A Stehouwer; Marleen M J van Greevenbroek
Journal:  Endocrine       Date:  2018-08-21       Impact factor: 3.633

5.  Complement factor C4a does not activate protease-activated receptor 1 (PAR1) or PAR4 on human platelets.

Authors:  Xu Han; Maria de la Fuente; Marvin T Nieman
Journal:  Res Pract Thromb Haemost       Date:  2020-12-04

Review 6.  Complement C4, Infections, and Autoimmune Diseases.

Authors:  Hongbin Wang; Mengyao Liu
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.